These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6149916)

  • 21. Metabolic fate of [14C] quercetin in the ACI rat.
    Ueno I; Nakano N; Hirono I
    Jpn J Exp Med; 1983 Feb; 53(1):41-50. PubMed ID: 6876476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The fate of ingested glyceran esters of condensed castor oil fatty acids [polyglycerol polyricinoleate (PGPR)] in the rat.
    Howes D; Wilson R; James CT
    Food Chem Toxicol; 1998; 36(9-10):719-38. PubMed ID: 9737418
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Studies of the enterohepatic circulation of morphine in the rat.
    Walsh CT; Levine RR
    J Pharmacol Exp Ther; 1975 Nov; 195(2):303-10. PubMed ID: 1185599
    [TBL] [Abstract][Full Text] [Related]  

  • 24. On the absorption, distribution and excretion of sorbinicate in the rat and the monkey.
    Giachetti C; Mondino A; Silvestri S; Zanolo G; Bramanti G; Criscuoli M; Subissi A
    Arzneimittelforschung; 1982; 32(11):1433-6. PubMed ID: 6891249
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics of (+/-)-4-diethylamino-1,1-dimethylbut-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate monohydrochloride monohydrate. 1st communication: absorption, distribution and excretion after single administration of 14C-labeled compound to rats and dogs.
    Nakamura A; Sugihara K; Hirota T; Morino A; Ezumi Y; Takaichi M
    Arzneimittelforschung; 1997 Feb; 47(2):151-9. PubMed ID: 9079234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of surfactant poloxalene 2930 on food intake, lipid absorption, and serum cholesterol in rats.
    Rodgers JB; Kyriakides EC; Bochenek WJ
    Exp Mol Pathol; 1984 Apr; 40(2):214-22. PubMed ID: 6705892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absorption, distribution, elimination and metabolism of 14C-heptaminol hydrochloride in rat.
    Chanoine F; Benedetti MS; Ancher JF; Dostert P
    Arzneimittelforschung; 1981; 31(9):1430-5. PubMed ID: 7197949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Absorption, distribution, metabolism and excretion of [14C]ebastine after a single administration in rats.
    Fujii T; Matsumoto S; Amejima H; Hatoyama T; Nakao M; Kagemoto A; Tanaka K; Miyazaki H
    Arzneimittelforschung; 1994 Apr; 44(4):527-38. PubMed ID: 7912071
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absorption, distribution and excretion of 14C-pirenzepine in rats. Accumulation characteristics after multiple dose regimen.
    Kobayashi S; Kyui S; Yoshida T; Nagakura A; Oiwa Y; Matsumura R; Kohei H
    Arzneimittelforschung; 1981; 31(4):679-90. PubMed ID: 6894697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Balance/excretion of 3H- and 14C-tyloxapol in the male rabbit after intratracheal administration.
    DeAngelis RL; Kearney MF; Barnes ER; Shockcor JP; Findlay JW
    Xenobiotica; 1995 May; 25(5):521-30. PubMed ID: 7571725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pre-clinical pharmacokinetics of the cyclooxygenase-inhibiting nitric oxide donor (CINOD) AZD3582.
    Fagerholm U; Breuer O; Swedmark S; Hoogstraate J
    J Pharm Pharmacol; 2005 May; 57(5):587-97. PubMed ID: 15901348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Distribution and excretion of chlordecone (Kepone) in the rat.
    Egle JL; Fernandez JB; Guzelian PS; Borzelleca JF
    Drug Metab Dispos; 1978; 6(1):91-5. PubMed ID: 74312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metabolic disposition of [14C] metanil yellow in rats.
    Singh RL
    Biochem Int; 1989 Nov; 19(5):1109-16. PubMed ID: 2635853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Toxicokinetics of allynitrile in rats.
    Farooqui MY; Ybarra B; Piper J
    Drug Metab Dispos; 1993; 21(3):460-6. PubMed ID: 8100502
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The kinetics of chlorite and chlorate in rats.
    Abdel-Rahman MS; Couri D; Bull RJ
    J Environ Pathol Toxicol Oncol; 1985; 6(1):97-103. PubMed ID: 4067839
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disposition of the new antirheumatic agent ethyl 4-(3,4-dimethoxyphenyl)- 6,7-dimethoxy-2-(1,2,4-triazol-1-ylmethyl)quinoline-3-carboxylate (TAK-603) in rats and dogs.
    Tagawa Y; Kiyota Y; Yoshimura Y; Motohashi M; Tanayama S
    Arzneimittelforschung; 1998 Jul; 48(7):750-7. PubMed ID: 9706376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation between the disposition of [14C]clofilium and its cardiac electrophysiological effect.
    Lindstrom TD; Murphy PJ; Smallwood JK; Wiest SA; Steinberg MI
    J Pharmacol Exp Ther; 1982 Jun; 221(3):584-9. PubMed ID: 7086672
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sucralfate: pharmacokinetics, metabolism and selective binding to experimental gastric and duodenal ulcers in animals.
    Steiner K; Bühring KU; Faro HP; Garbe A; Nowak H
    Arzneimittelforschung; 1982; 32(5):512-8. PubMed ID: 6896647
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Effect of polychlorinated biphenyls in the rat. III - PCB distribution, storage and elimination relation time (author's transl)].
    Narbonne JF; Gillet G; Daubeze M
    Toxicol Eur Res; 1978 Jul; 1(4):217-27. PubMed ID: 105428
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics, protein binding and metabolic profile of 3H-icometasone enbutate following intravenous, oral and intratracheal administrations to Sprague-Dawley rats.
    Duchêne P; Giudicelli MD; Neau B; Gronfier A; Firmin Y; Villax P; Saivin S; Houin G
    Arzneimittelforschung; 1998 Apr; 48(4):371-8. PubMed ID: 9608879
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.